The Beijing Robotics Fund, a subsidiary of Shoucheng Capital, has made strategic investments in Xinghaitu and Tupai, two pioneering enterprises. This move aims to propel product innovation and upgrades, thereby enhancing their global competitiveness. Xinghaitu specializes in the research and development of embodied intelligent robots, while Tupai concentrates on advanced ophthalmic medical devices.
